Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Receivables - Other: 2016-2024

Historic Receivables - Other for Seres Therapeutics (MCRB) over the last 6 years, with Dec 2024 value amounting to $2.7 million.

  • Seres Therapeutics' Receivables - Other was N/A to $53,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $53,000, marking a year-over-year change of. This contributed to the annual value of $2.7 million for FY2024, which is 69.07% down from last year.
  • According to the latest figures from FY2024, Seres Therapeutics' Receivables - Other is $2.7 million, which was down 69.07% from $8.7 million recorded in FY2023.
  • In the past 5 years, Seres Therapeutics' Receivables - Other ranged from a high of $8.7 million in FY2023 and a low of $2.7 million during FY2024.
  • For the 2-year period, Seres Therapeutics' Receivables - Other averaged around $5.7 million, with its median value being $5.7 million (2023).
  • In the last 5 years, Seres Therapeutics' Receivables - Other surged by 494.71% in 2020 and then plummeted by 69.07% in 2024.
  • Seres Therapeutics' Receivables - Other (Yearly) stood at $8.2 million in 2020, then reached $8.7 million in 2023, then tumbled by 69.07% to $2.7 million in 2024.